We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Featured Products View All

 
 

Product News View All

New Collaboration Explores Efficacy of Gene Delivery Vector Tech in Diabetes and Multiple Sclerosis
Product News

Amarna Therapeutics has announced today that it has entered into a collaboration with scientists from the Progreso y Salud Foundation (FPS) at Cabimer in Seville, to jointly examine the efficacy of Amarna’s SVec™ gene delivery vector for the development of effective immunotherapies for diabetes mellitus type 1 (DM1) and multiple sclerosis (MS).

READ MORE

First Data on Using a Therapeutic Form of ACE2 To Treat COVID-19 Published
Product News

A case report published today in The Lancet Respiratory Medicine outlines the first compassionate use of recombinant soluble human ACE2 (APN01) to treat a female 45-year-old patient who was diagnosed with severe COVID-19.

READ MORE

Canada’s Largest Research Hospital Selects ImmunoGenomiX Platform To Analyze Immune Sequencing Data
Product News

ENPICOM, an innovative bioinformatics software engineering company specialized in decoding the immune system, announced that the Princess Margaret Cancer Centre of the University Health Network (UHN) has purchased a subscription to ENPICOM’s data analysis platform.

READ MORE

ERS Genomics Announces Agreement With Applied StemCell To Commercialize CRISPR Gene Editing Solutions
Product News

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property announced it has signed an agreement with Applied StemCell, Inc., a leading provider of stem cell, animal model, antibody discovery services and reagents to commercialize CRISPR gene editing.

READ MORE

 
Advertisement